Indian pharmaceutical companies are stepping up their efforts to combat the problem of counterfeit drugs, employing a variety of strategies, from packaging innovations to engaging private investigation agencies. The stakes are high, as counterfeit medicines not only harm consumers but also tarnish the reputation of leading brands.

Kareena Kapoor attends a Bvlgari event in style.

The top 300 pharmaceutical brands in the country will now bear a quick response (QR) code on their packaging to rein in spurious drugs and ensure better traceability.

Announcing the news on social media, Symonds, 32, said the baby was named after the UK Prime Minister's grandfather Wilfred and her grandfather Lawrie, with Nicholas a nod to the National Health Service doctors - Dr Nick Price and Dr Nick Hart.

An ardent backer of Brexit, Boris Johnson has a reputation for brashness, bombast, bending the truth, and really bad hair, which has earned him more than a few comparisons to United States President Donald Trump (who also happens to be a fan of his). Here are some interesting facts about BoJo, as he is called by the British media.

It is advisable to stick to mid-caps with sustainable financial metrics rather than those offering the promise of faster growth.

As Michael Kors takes over the Italian fashion house, we take a trip down memory lane and look back at the Versace story.

A look at some interesting moments from the 10-day fashion gala in New York.

Dermatologist Dr Aparna Santhanam hosted a chat with readers last month to help them deal with skincare problems. For those of you who missed it, here's the transcript.

According to Dr Reddy's, the drugmaker may launch Rivastigmine, an anti-mild-to-moderate Alzheimer's drug, Desloratadine, used to treat allergies and Pseudoephedrine, a nasal/sinus decongestant.

Dr Reddy's Laboratories received a major setback in the US, as a court there granted a motion seeking a preliminary injunction to block the launch of its generic version of Sanofi-Aventis' anti-allergic drug, Allegra D24.

The patent relates to the manufacturing process for the active ingredient in Sanofi-Aventis' Allegra and Allegra-D drug products. Both Dr Reddys and Sandoz are known to be marketing these products in the US.

Susi Ganesan's Tamil movie starring Vikram and Shriya Saran tries to be intelligent -- but fails.

The Telugu remake of Susi Ganesan's Tamil movie Kandasamy is heavy on slickness and technical finesse rather than substance.

Taken together, it looks like Devi Sri Prasad has decided to bow down to the pressures of a commercial entertainer, and come up with an album that's a lot of sound, fury and (borrowed) tunes.

Aventis Pharma, the Indian arm of sanofi-aventis, the world's third largest drug company, is planning to ramp up its domestic operations with acquisition of brands and make India a major hub for its research and development and manufacturing activities. At present, sanofi-aventis has two large manufacturing facilities, one at Ankleswar for active pharmaceutical ingredients and the other in Goa for making tablets.

A new study reveals how drug brand names are hijacked by online pharmacies that churn out spam e-mails and hawk counterfeit pills.

In the cataclysmic fall by techs led by Infosys, the sudden downturn by Dr Reddy's Labs late Friday went virtually innoticed.

Indian drugmaker Dr Reddy's Laboratories Ltd said on Wednesday it has filed with the US Food and Drug Administration to market a generic version of Aventis Pharmaceuticals' anti-allergy drug Allegra.

Dr Reddy's shrugged off recent volatility on Wednesday and moved tenaciously on filing new gernerics with the US FDA.